Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis

Rheumatoid arthritis (RA) is a painful and incurable disease characterized by chronic joint inflammation and a progressive destruction of cartilage and bone. Although current treatments have improved clinical outcomes for some patients, the high relapse rates and sizeable proportion of non-responder...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Patrick P., Leifer, Franziska Graf, Basso, Jessica, Lasala, Dan, Li, Dedong, Chen, Kuan-Ju, Zhang, Jimin, Perkins, Walter R., Cipolla, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451067/
https://www.ncbi.nlm.nih.gov/pubmed/37638021
http://dx.doi.org/10.3389/fimmu.2023.1231047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451067/
https://www.ncbi.nlm.nih.gov/pubmed/37638021
http://dx.doi.org/10.3389/fimmu.2023.1231047

Ejemplares similares